Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer.

Cancer prevention research (Philadelphia, Pa.) - 1 Nov 2015

Ahn-Jarvis Jennifer H, Clinton Steven K, Grainger Elizabeth M, Riedl Kenneth M, Schwartz Steven J, Lee Mei-Ling T, Cruz-Cano Raul, Young Gregory S, Lesinski Gregory B, Vodovotz Yael

Abstract excerpt

Epidemiologic associations suggest that populations consuming substantial amounts of dietary soy exhibit a lower risk of prostate cancer. A 20-week randomized, phase II, crossover trial was conducted in 32 men with asymptomatic prostate cancer. The crossover involved 8 weeks each of soy bread (SB) and soy-almond bread (SAB). The primary objective was to investigate isoflavone bioavailability and metabolite...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Availability
Share to Bread

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Over Studies

Share to Doxorubicin

Share to Glucosides

Share to Insulin-Like Growth Factor Binding Proteins

Share to Isoflavones

Share to Somatomedins

Source

Open in PubMed Open full text

Identifiers

PMID: 26276749
DOI: 10.1158/1940-6207.CAPR-14-0465
PMCID: PMC4633369

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer.PMID 26276749Read ↗

Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells.Semantic proximity Read ↗

Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomicsSemantic proximity Read ↗

Polymorphisms in genes involved in the metabolism and transport of soy isoflavones affect the urinary metabolite profile in premenopausal women following consumption of a commercial soy supplement as a single bolus dose.Semantic proximity Read ↗

Soy Isoflavones Alter Expression of Genes Associated with Cancer Progression, Including Interleukin-8, in Androgen-Independent PC-3 Human Prostate Cancer CellsSemantic proximity Read ↗

Isoflavones and coumestrol in soybeans and soybean products from Australia and IndonesiaSemantic proximity Read ↗

Rapid gut transit time and slow fecal isoflavone disappearance phenotype are associated with greater genistein bioavailability in women.Semantic proximity Read ↗

The apparent absorptions of isoflavone glucosides and aglucons are similar in women and are increased by rapid gut transit time and low fecal isoflavone degradation.Semantic proximity Read ↗

Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls.Semantic proximity Read ↗

Lunasin concentration in different soybean genotypes, commercial soy protein, and isoflavone products.Semantic proximity Read ↗

High urinary isoflavone excretion phenotype decreases plasma cholesterol in golden Syrian hamsters fed soy protein.Semantic proximity Read ↗

Effects of soy protein and soy phytochemicals on mammary tumor development in female transgenic mice overexpressing human pituitary growth hormone.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.